Aktivitas Leukosit Pro Inflamasi pada Kasus Penyakit Paru Obstruktif Kronis Eksaserbasi Akut
Abstract
Penyakit Paru Obstruktif Kronis (PPOK) memiliki karateristik adanya restriksi saluran nafas yang kurang reversibel. Pada PPOK terdapat inflamasi akibat aktifitas sel-sel inflamasi termasuk neutrofil dan eosinofil. Restriksi saluran nafas terjadi akibat remodelling dari proses inflamasi yang terjadi. Penelitian ini bertujuan untuk mengetahui aktifitas sel-sel inflamasi terutama neutrofil dan eosinofil pada PPOK eksaserbasi akut dengan membandingkan kadar eosinfil dan netrofil sebelum dan sesudah terapi. Penelitian bersifat observasional dengan desain cross sectional. Responden penelitian ini adalah pasien penderita PPOK yang rawat jalan dan rawat inap di RSUD Kebumen pada tahun 2016. Semua subyek masuk dalam penelitian dengan kriteria eksklusi adalah data tidak lengkap. Hasil menunjukkan terdapat 119 pasien yang memenuhi kriteria inklusi sebagai responden. Data dari rekam medis menunjukkan bahwa mayoritas penderita adalah laki-laki (84,03 %) dengan rata-rata umur 67 tahun. Penyakit penyerta yang ditemukan adalah hipertensi (54,62 %), tuberkulosis (22,69 %) dan congestive heart failure (CHF) (6,72 %). Pada tanda vital, terdapat kenaikan sistole dan laju nafas. Presentase netrofil pada kedua jenis kelamin meningkat dibandingkan normal namun tidak dengan eosinofil. Setelah dilakukan rawat inap, terjadi penurunan persentase eosinofil dan neutrofil dibanding sebelum perawatan namun tidak signifikan secara statistik (p= 0,603 vs 0,818). Kesimpulan dari penelitian ini adalah adanya peningkatan aktivitas netrofil pada pasien PPOK. Penurunan aktivitas baik netrofil maupun eosinofil didapatkan ketika pasien rawat inap meskipun tidak bermakna secara statistik.
Keywords
Full Text:
Download ArticleReferences
Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL. Harrison’s Principles of Internal Medicine. 16th ed. New York: The McGraw-Hill Companies. 2005.
Gorczynski R, Stanley J. Clinical immunology. Texas: landes Bioscience. 1999.
Cruse JM, Lewis RE. Illustrated Dictionary of Immunology (2nd Edition). London, UK: Taylor & Francis. 2003.
Hoppenot D, Malakauskas K, Lavinskienė S, Bajoriūnienė I, Kalinauskaitė V, Sakalauskas R. Peripheral Blood Th9 Cells and Eosinophil Apoptosis in Asthma Patients. Medicina (Kaunas), 2015; 51 (1): 10–17.
Saeki M, Kaminuma O, Nishimura T, Kitamura N, Mori A, Hiroi T. Th9 Cells Elicit EosinophilIndependent Bronchial Hyperresponsiveness in Mice. Allergol Int, 2016; 65 (Suppl): S24–S29.
Lukawska JJ, Livieratos L, Sawyer BM, Lee T, O’Doherty M, Blower PJ, et al. Imaging Inflammation in Asthma: Real Time, Differential Tracking of Human Neutrophil and Eosinophil Migration in Allergen Challenged, Atopic Asthmatics in Vivo. EBioMedicine, 2014; 1 (2): 173–180.
Mazzeo C, Cañas JA, Zafra MP, Rojas MA, Fernández-Nieto M, Sanz V, et al. Exosome Secretion by Eosinophils: A Possible Role in Asthma Pathogenesis. J Allergy Clin Immunol, 2015; 135 (6): 1603–1613.
Zeiger RS, Schatz M, Dalal AA, Chen W, Sadikova E, Suruki RY, et al. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study. J Allergy Clin Immunol Pract, 2016; 5 (1): 144-153.
Karch A, Vogelmeier C, Welte T, Bals R, Kauczor HU, Biederer J, et al. The German COPD Cohort COSYCONET: Aims, Methods and Descriptive Analysis of the Study Population at Baseline. Respir Med. 2016; 114 (1): 27–37.
Hagstad S, Backman H, Bjerg A, Ekerljung L, Ye X, Hedman L, et al. Prevalence and Risk Factors of COPD among Never-Smokers in Two Areas of Sweden - Occupational Exposure to Gas, Dust or Fumes is an Important Risk Factor. Respir Med, 2015; 109 (11): 1439–1445.
Jenkins CR, Chapman KR, Donohue JF, Roche N, Tsiligianni I, Han MK. Improving the Management of COPD in Women. Chest. 2016; 151 (3): 686-696.
Melzer AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, McBurnie MA, Mularski RA, et al. Patient Characteristics Associated with Poor Inhaler Technique among a Cohort of Patients with COPD. Respir Med, 2017; 123 (1): 124-130.
Fragoso E, Andr S, Boleo-Tom JP, Areias V, Munh J, Cardoso J. Understanding COPD: A Vision on Phenotypes, Comorbidities and Treatment Approach. Rev Port Pneumol. 2016; 22 (2): 101–111.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2006.
O’Toole RF, Shukla SD, Walters EH. TB Meets COPD: An Emerging Global Co-Morbidity in Human Lung Disease. Tuberculosis. 2015; 95 (6): 659–663.
Gunen H, Yakar H. The Role of TB in COPD. Chest, 2016; 150 (4): 856A.
Mohamed-Hussein AAR, Gamal EW, Abd Allah MS. Value of Blood Eosinophilia in PhenotypeDirected Corticosteroid Therapy of COPD Exacerbation: Final Results. Egypt J Chest Dis Tuberc, 2016; 66 (1): 221-225.
Pedersen F, Marwitz S, Holz O, Kirsten A, Bahmer T, Waschki B, et al. Neutrophil Extracellular Trap Formation and Extracellular DNA in Sputum of Stable COPD Patients. Respir Med, 2015; 109 (10): 1360–1362.
Yousef AM, Alkhiary W. Role of Neutrophil to Lymphocyte Ratio in Prediction of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Egypt J Chest Dis Tuberc, 2016; 66 (1): 1-6.
Kuna P, Jenkins M, O’Brien CD, Fahy WA. AZD. A Neutrophil Elastase Inhibitor, Plus ongoing Budesonide/ Formoterol in Patients with COPD. Respir Med, 2012; 106 (4): 531–539.
Gupta V, Khan A, Higham A, Lemon J, Sriskantharajah S, Amour A, et al. The Effect of Phosphatidylinositol-3 Kinase Inhibition on Matrix Metalloproteinase-9 and Reactive Oxygen Species Release from Chronic Obstructive Pulmonary Disease Neutrophils. Int Immunopharmacol, 2016; 35 (1): 155–162.
Oudijk EJD, Gerritsen WBM, Nijhuis EHJ, Kanters D, Maesen BLP, Lammers JWJ, et al. Expression of Priming-Associated Cellular Markers on Neutrophils during an Exacerbation of COPD. Respir Med, 2006; 100 (10): 1791– 1799.
Lerner CA, Sundar IK, Rahman I. Mitochondrial Redox System, Dynamics and Dysfunction in Lung Inflammaging and COPD. Int J Biochem Cell Biol, 2016; 81 (Pt. B): 294–306.
DOI: https://doi.org/10.18196/mm.170202
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Editorial Office:
Journal Room, G1 (Biomedic) Building, Ground Floor, Faculty of Medicine and Health Science Universitas Muhammadiyah Yogyakarta,
Jalan Lingkar Selatan (Brawijaya), Tamantirto, Kasihan, Bantul, Daerah Istimewa Yogyakarta, Indonesia
Phone: +62 274 387 656 (ext: 231)
WA : +62 811-2650-303
Website: http://journal.umy.ac.id/index.php/mm
E-mail: mmjkk@umy.university
Mutiara Medika: Jurnal Kedokteran dan Kesehatan is licensed under a Creative Commons Attribution 4.0 International License. View My Stats